|
|
|
Volumn 26, Issue 4 SUPPL. 12, 1999, Pages 41-50
|
|
An overview of monoclonal antibody therapy of cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIIDIOTYPIC ANTIBODY;
IMMUNOGLOBULIN IDIOTYPE;
IMMUNOTOXIN;
MONOCLONAL ANTIBODY;
ONCOPROTEIN;
RITUXIMAB;
TRASTUZUMAB;
UNCLASSIFIED DRUG;
ACUTE GRANULOCYTIC LEUKEMIA;
ADVANCED CANCER;
ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY;
ANTIGEN SPECIFICITY;
ARTICLE;
BREAST CANCER;
CANCER THERAPY;
DRUG EFFICACY;
GENE TARGETING;
IMMUNE RESPONSE;
IMMUNOGLOBULIN STRUCTURE;
ONCOGENE NEU;
PRIORITY JOURNAL;
TARGET CELL;
ANIMALS;
ANTIBODIES, MONOCLONAL;
BIOLOGICAL RESPONSE MODIFIERS;
BREAST NEOPLASMS;
HUMANS;
IMMUNOCONJUGATES;
IMMUNOGLOBULIN G;
IMMUNOTOXINS;
NEOPLASMS;
RECEPTOR, ERBB-2;
|
|
EID: 0032851960
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (90)
|
|
References (43)
|
